Table 2.

Effects of Herbimycin A on IFN-γ–Induced PLA2 Activity and AA Release by HL-60 Cells

TreatmentPLA2 Activity (% control)AA Release (% control)
MembraneCytosol
None 100 ± 14 100 ± 8 100 ± 12 
IFN-γ 248 ± 24* 241 ± 23* 652 ± 43* 
12 hours 
Herbimycin A 102 ± 12 106 ± 13 104 ± 12 
Herbimycin A + IFN–γ 98 ± 13 106 ± 12 637 ± 36* 
16 hours 
Herbimycin A 103 ± 14 107 ± 15 99 ± 11 
Herbimycin A + IFN–γ 104 ± 12 111 ± 13 611 ± 65* 
20 hours 
Herbimycin A 109 ± 12 112 ± 15 103 ± 8 
Herbimycin A + IFN–γ 102 ± 7 104 ± 13 656 ± 47* 
TreatmentPLA2 Activity (% control)AA Release (% control)
MembraneCytosol
None 100 ± 14 100 ± 8 100 ± 12 
IFN-γ 248 ± 24* 241 ± 23* 652 ± 43* 
12 hours 
Herbimycin A 102 ± 12 106 ± 13 104 ± 12 
Herbimycin A + IFN–γ 98 ± 13 106 ± 12 637 ± 36* 
16 hours 
Herbimycin A 103 ± 14 107 ± 15 99 ± 11 
Herbimycin A + IFN–γ 104 ± 12 111 ± 13 611 ± 65* 
20 hours 
Herbimycin A 109 ± 12 112 ± 15 103 ± 8 
Herbimycin A + IFN–γ 102 ± 7 104 ± 13 656 ± 47* 

Cells were treated for 12, 16, and 20 hours with herbimycin A (1 μg/mL). When PLA2 activity was to be measured, cells were stimulated with 2,000 U/mL of IFN-γ during the last 4 hours of the incubation period with herbimycin A. PLA2 activity in particulate and soluble fractions was determined by hydrolysis of [arachidonyl-14C]PtdCho in the presence of 5 mmol/L DTT and 150 nmol/L Ca2+. When AA release was to be measured, cells were labeled with 5 μCi/mL of [3H]arachidonic acid for 60 minutes and stimulated with IFN-γ (2,000 U/mL) for 2 minutes at the end of incubation period with herbimycin A. After treatment, cells were pelleted and the resulting supernatant was counted to determine levels of released label. The data (means ± SD) are expressed as percentage of the control level obtained from three independent experiments assayed in duplicate.

*

Significantly different (P < .05, Student's t-test) from controls.

or Create an Account

Close Modal
Close Modal